References
- Schimff SC. Therapy of infection in patients with granulocytopenia. Med Clin North Am 1977; 61: 1101–1118
- Love LJ, Schimff SC, Schiffer CA, Wiernik PH. Improved prognosis for granulocytopenic patients with gram-negative bacteremia. Am J Med 1980; 68: 643–648
- Wade JC, Schimff SC, Newman KA, Wiernik PH. Staphylococcus epidermidis: An increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982; 97: 503–508
- Levine AS, Schimff SC, Graw RG, Jr., Young RC. Hematological malignancies and other marrow failure states: Progress in the management of complicating infections. Semin Hematol 1974; 11: 141–202
- EORTC International Antimicrobial Therapy Project Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 1978; 137: 14–29
- Keating MJ, Bodey GP, Valdivieso M, Rodriques V. A randomized comparative trial of three aminoglycosides—comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine 1979; 58: 159–170
- Schleifer DT, Mulder NH, Vries-Hospers HG, Fidler V, Nieweg HO, Van der Waaij D, Van Saenes KF. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 1980; 16: 859–869
- Nauseff WM, Maki DG. A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med 1981; 304: 448–453
- Schimff SC, Yong VM, Green WH, Vermenten GD, Moody MR, Wiernik PH. Origin of infection in acute nonlymfocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 1972; 77: 707–714
- Valdivieso M, Keating MJ, Feld R, Rodriquez V, Bodey GP. Review of experience with amikacin and other aminoglycoside antibiotics in the treatment of infectious complications in patients with cancer. U.S amikacin symposium. Am J Med. 1977; 204–211